LOS ANGELES, March 15, 2017 -- City National Bank today announced that it will increase its prime lending rate from 3.75 percent to 4.00 percent, effective March 16, 2017.
About City National
With $45.1 billion in assets, City National Bank provides banking, investment and trust services through 72 offices, including 16 full-service regional centers, in Southern California, the San Francisco Bay Area, Nevada, New York City, Nashville and Atlanta. In addition, the company and its investment affiliates manage or administer $55.5 billion in client investment assets.
City National is a subsidiary of Royal Bank of Canada (RBC), one of North America’s leading diversified financial services companies. RBC serves more than 16 million personal, business, public sector and institutional clients through offices in Canada, the United States and 35 other countries.
For more information about City National, visit the company’s website at cnb.com.
Media: Cary Walker, City National Bank, 213.673.7615 [email protected]


Anthropic IPO Could Challenge SpaceX’s Record $86 Billion Offering
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
REPAY Stock Rises After Visa Platform Connect Collaboration
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Amazon to Expand Drone Delivery to 500 U.S. Locations
SpaceX Hires Natural Gas Trader to Meet Growing Energy Needs
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
OpenAI Tightens AI Safety Monitoring After Security Incidents
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement
Samsung Shares Rise on $72 Billion Shareholder Return Plan
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook 



